BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dr. Peter Covitz Joins MDS Nordion (MDZ) as Senior Vice-President


2/6/2008 8:11:05 AM

OTTAWA, Feb. 5 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has appointed Dr. Peter Covitz to the newly created position of Senior Vice-President Innovation. Dr. Covitz will lead the global effort for developing and implementing new technology strategies and identifying new complimentary business opportunities to better serve customers and support growth at MDS Nordion.

"This new role demonstrates the value we place on engaging creative and dynamic thinkers and I'm thrilled Dr. Covitz is joining our team," said Steve West, President, MDS Nordion. "Acting as the primary scientific liaison, Dr. Covitz will advance our global innovation programs by identifying opportunities, setting up collaborations, and driving ideas to commercialization."

Dr. Covitz will report directly to Steve West, President of MDS Nordion and will be a member of the MDS Nordion Executive Management Team and a representative on the MDS Scientific Advisory Board.

Dr. Covitz comes to MDS Nordion from the National Cancer Institute (NCI) in Maryland, United States, where he held the position of Chief Operating Officer at the NCI's Center for Biomedical Informatics and Information Technology. He holds a Ph.D in Microbiology from Columbia University and a B.A. with a major in biology from Colgate University. Dr. Covitz holds a number of patents and is widely published in scientific journals.

About MDS Nordion

MDS Nordion (www.mdsnordion.com) is a world leader in medical isotopes, radiation and related technologies. It is a business unit of MDS Inc. . MDS is a global life sciences company that provides market-leading products and services our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS Inc. has more than 5,500 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.

CONTACT: Media: Tamra Benjamin, Director Marketing and External
Communications, MDS Nordion, (613) 592-3400 ext. 1022,
tamra.benjamin@mdsinc.com; Investors: Sharon Mathers, Senior
Vice-President, Investor Relations and External Communications, MDS Inc.,
(416) 675-6777 x 34721, sharon.mathers@mdsinc.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES